Clinical trial
Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours…
NCT00343174 · Heidelberg University, Other · Completed
Key facts
| NCT number | NCT00343174 |
|---|---|
| Title | Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms |
| Official title | Multicenter Parallel Randomized Double-Blind Placebo Controlled Study of Efficacy and Safety of Intravenous Ancrod ( Arvin ) Given Within 6 Hours After the Onset of Acute Ischemic Stroke: European Stroke Treatment With Ancrod Trial ESTAT |
| Lead sponsor | Heidelberg University, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain Infarction, Cerebral Ischemia, Acute Stroke |
| Intervention type | Drug |
| Interventions | Ancrod |
| First posted | Jun 22, 2006 |
| Last update posted | Jun 22, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: